Determination of the Glycemic Index Values of 10 Cereal-based Products (NCT06710743) | Clinical Trial Compass
CompletedNot Applicable
Determination of the Glycemic Index Values of 10 Cereal-based Products
Australia10 participantsStarted 2024-07-01
Plain-language summary
To determine the Glycemic index values for 10 cereal-based products
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 10 healthy participants, male and female (non-pregnant, non-lactating) of mixed ethnicity, aged between 18 - 65 y
* BMI: 18 - 25.0 kg/m2 (bounds included)
* Non smokers
* Normal glucose tolerance (assessed by 50 gram oral glucose tolerance test performed within the last 30 days: fasting \<6 mM, 2 hr glucose \<7.8 mM)
* Stable weight and dietary habits. Normal eating patterns and no history of eating disorders or recent dieting
* Normal sleep patterns (ie. at least 6 hours of sleep per night)
* The participants are required to avoid alcohol and unusual levels of food intake and physical activity for the 24 hours before each test session.
* Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigator on the basis of medical history. Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.
Exclusion Criteria:
* Food allergy or intolerance to the study ingredients (eg. gluten, etc.)
* Regularly taking prescription medication other than standard contraceptive medication
* Taking any medications known to affect glucose tolerance (eg. acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis)
* Suffering from any illness or disease
* Following a restricted diet
* Smokers
* Eating disorders
* Abnormal glucose tolerance…
What they're measuring
1
Glycemic index (GI) values
Timeframe: Two hour test session per visit. Visits must be at least two days apart. Including Screening, the study duration is approximately four to eleven weeks depending on whether participants are available to be tested one, two or three times per week.